End-of-day quote
Other stock markets
|
||
- USD | - |
05-09 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (ALT) ALTIMMUNE Reports Q1 Revenue $5,000 | MT |
Sales 2024 * | - | Sales 2025 * | 33.33M 45.57M | Capitalization | 512M 700M |
---|---|---|---|---|---|
Net income 2024 * | -102M -139M | Net income 2025 * | -147M -201M | EV / Sales 2024 * | - |
Net cash position 2024 * | 63.88M 87.33M | Net cash position 2025 * | 257M 351M | EV / Sales 2025 * | 7.66 x |
P/E ratio 2024 * |
-5.06
x | P/E ratio 2025 * |
-5.44
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.22% |
Latest transcript on Altimmune Inc
Managers | Title | Age | Since |
---|---|---|---|
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 18-11-29 |
Director of Finance/CFO | 66 | 21-12-30 | |
Anthony Blandin
CMP | Compliance Officer | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchel Sayare
CHM | Chairman | 76 | 10-03-31 |
Mack Gill
BRD | Director/Board Member | 72 | 04-07-31 |
Philip Hodges
BRD | Director/Board Member | 56 | 03-08-31 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |